Search results
Results from the WOW.Com Content Network
[82] [83] Memantine and amantadine are said to have moderate anti-akinetic effects in the treatment of Parkinson's disease. [78] [88] The doses of memantine used for Parkinson's disease are about 5- to 10-fold lower than those of amantadine, which has been attributed to greater potency of memantine. [78]
Neurobiological Technologies, Inc. ("NTI") was a biotechnology company that was founded in 1987 by Enoch Callaway and John B. Stuppin to in-license and develop drugs primarily to treat neurological conditions; the company was dissolved in 2009 after the failure of its drug candidate ancrod in a Phase III trial for ischemic stroke.
Safeway tried to imitate the model that had been successful in California, but Chicago's strong ethnic background did not mesh well with the California shopping experience. Between 2002 and 2007, Dominick's market share in the Chicago region declined from 24.4 percent to 14.5 percent (Jewel-Osco's 40.5 percent was the market's leader). [21]
At its peak, White Hen had 245 stores in the Chicago region and 55 in the Boston area. White Hen's decline began in 2000, around the time it was sold to Clark Retail Group.
Memantine/donepezil, sold under the brand name Namzaric among others, is a fixed dose combination medication used for the treatment of dementia of the Alzheimer's type. [1] It contains memantine , as the hydrochloride, a NMDA receptor antagonist ; and donepezil as the hydrochloride, an acetylcholinesterase inhibitor . [ 1 ]
The museum previously refused to attribute the painting to Van Gogh when approached by the previous owner in December 2018. However, LMI, which acquired the painting in 2019, is confident that it ...
Like memantine, nitromemantine is a low-affinity voltage-dependent uncompetitive antagonist at glutamatergic NMDA receptors, however nitromemantine selectively inhibits extrasynaptic NMDA receptors while sparing normal physiological synaptic NMDA receptor activity, resulting in less side effects and a greater neuroprotective action, as well as stimulating regrowth of synapses with prolonged ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.